Aurobindo Pharma anticipates its China facility will achieve break-even by Q3 FY26. Production is ramping up after commencing operations in November 2024. The company invested USD 145 million in the facility. Aurobindo Pharma also invested in US facilities and plans to file for products in the US and Europe.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Hs24qbj
via IFTTT
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
So I’m currently on a lean bulk on 2900 a day. And I wake up 6 am I have oats and protein powder or fruit then go gym around 9 am Then at ...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(529)
-
▼
August
(41)
- IMA warns of misuse, mis-prescription of new weigh...
- Novo Nordisk warns patients after theft of weight-...
- CDSCO issues alert on Novo drugs after reported theft
- Substantial cancer drugs beyond ambit of current p...
- Stricter shelf life rule a bitter pill to swallow ...
- Drugmaker Novo Nordisk freezes hiring for non-crit...
- Natco Pharma launches generic drug with 180-day ex...
- When the heart and sugar collide: The overlooked r...
- Aurobindo Pharma closing in on $5.5b Zentiva buyout
- Indian drugmakers seek exemption for generics from...
- Glenmark, Alembic Pharma, Sun Pharma recall produc...
- Alembic gets USFDA nod for generic drug for skin c...
- Aurobindo Pharma expects China plant to break even...
- Food Chained: How weight-loss drugs are changing I...
- Max Healthcare to nearly double capacity to 9,500 ...
- Cohance Lifesciences announces $10 million investm...
- From burden to breakthrough: Reimagining the #Weig...
- Intas Pharma completes acquisition of UDENYCA bios...
- Lupin ties up with Sandoz to commercialise biosimi...
- Chemists seek ban on quick commerce sale of prescr...
- Asia Healthcare Holdings to invest Rs 400 crore in...
- Pfizer launches next-gen vaccine for pneumococcal ...
- Welcure Drugs & Pharma board to consider share spl...
- Zydus Lifesciences gets USFDA approval for angina,...
- Retinal disorders a public health crisis, need imm...
- Managing diabetes in a country obsessed with quick...
- Govt gives BIS exemption to parts used in medical ...
- Biocon sees GLP-1 weight-loss therapy as a future ...
- Medical device firms sound the alarm over new stee...
- Weight-loss drug Mounjaro crosses Rs 100 crore sal...
- Novo Nordisk's Wegovy, Mounjaro sales in India dou...
- Executive order by US administration excludes Phar...
- Indian pharma on alert as US mulls higher drug tar...
- More heart attacks in diabetes? Here’s what you sh...
- Indian generics wave next year set to sink obesity...
- Eris Lifesciences eyes ‘good’ share in semaglutide...
- Pharma tariffs may go as high as 250%, says Trump
- Mind, muscle, and metabolism: The power of holisti...
- Corner Office Conversation with The New Leaders of...
- Manipal Hospitals seeks CCI nod to acquire Sahyadr...
- 70% enrolment of participants for Phase III clinic...
-
▼
August
(41)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment